Celularity (CELUW) Current Deferred Revenue (2019 - 2025)
Celularity (CELUW) reported Current Deferred Revenue of $5.3 million for Q4 2025, down 15.99% year-over-year from $6.3 million in Q4 2024, and down 5.89% quarter-over-quarter from $5.6 million in Q3 2025.
Celularity (CELUW) Current Deferred Revenue (2019 - 2025) Analysis & Trends
Celularity (CELUW) has 7 years of Current Deferred Revenue data on file, last reported at $5.3 million in Q4 2025.
- Current Deferred Revenue for Q4 2025 came in at $5.3 million, down 15.99% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.3 million (down 15.99% YoY), and the FY2025 annual result was $5.3 million, down 15.99% from the prior year.
- Current Deferred Revenue fell to $5.3 million in Q4 2025 per CELUW's latest filing, from $5.6 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $11.9 million in Q1 2021 and troughed at $2.8 million in Q1 2024.
- A 5-year average of $5.6 million and a median of $5.0 million in 2023 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2021 and 2025: Current Deferred Revenue slumped 72.08% in 2021, then soared 123.81% in 2025.
- A 5-year view of Current Deferred Revenue shows it stood at $4.1 million in 2021, then rose by 10.45% to $4.5 million in 2022, then jumped by 34.02% to $6.0 million in 2023, then climbed by 3.9% to $6.3 million in 2024, then decreased by 15.99% to $5.3 million in 2025.
- Business Quant data shows CELUW's Current Deferred Revenue at $5.3 million in Q4 2025, $5.6 million in Q3 2025, and $6.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Celularity | - | - | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.26 Mn |
| Sep 30, 2025 | 5.58 Mn |
| Jun 30, 2025 | 6.37 Mn |
| Mar 31, 2025 | 6.28 Mn |
| Dec 31, 2024 | 6.26 Mn |
| Sep 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 6.23 Mn |
| Mar 31, 2024 | 2.81 Mn |
| Dec 31, 2023 | 6.02 Mn |
| Sep 30, 2023 | 5.56 Mn |
| Jun 30, 2023 | 4.67 Mn |
| Mar 31, 2023 | 4.52 Mn |
| Dec 31, 2022 | 4.49 Mn |
| Sep 30, 2022 | 4.36 Mn |
| Jun 30, 2022 | 4.23 Mn |
| Mar 31, 2022 | 4.11 Mn |
| Dec 31, 2021 | 4.07 Mn |
| Sep 30, 2021 | 3.82 Mn |
| Jun 30, 2021 | 11.16 Mn |
| Mar 31, 2021 | 11.85 Mn |